Physician profile
Roberto Taarea
NPI 1649478116
$17,982.94
in general payments reported to CMS, 2019-2025
15 companies · $5,280 in 2025
The $5,280 reported for 2025 was more than what 89% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.43 · 2022: $6,329 · 2023: $39.72 · 2024: $6,252 · 2025: $5,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,588 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,150 · Travel and Lodging: $2,537 · Food and Beverage: $2,287 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,588.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,150.00 |
| Travel and Lodging | $2,536.91 |
| Food and Beverage | $2,287.49 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $10,325.39 | 2022-2025 | |
| Intuitive Surgical, INC. | $4,855.40 | 2024-2025 | |
| Tela Bio, INC. | $2,060.66 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $147.21 | 2024 | Airseal |
| Solventum Corporation | $115.33 | 2024 | Prevena, Bair Paws, V.A.C. Veraflo Cleanse Choice |
| Applied Medical Resources Corporation | $103.00 | 2025 | |
| Kerecis Limited | $99.41 | 2022 | |
| Kci USA, INC. | $82.43 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $68.49 | 2025 | Imfinzi |
| Pacira Pharmaceuticals Incorporated | $24.78 | 2022 | |
| Davol INC. | $24.07 | 2023 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $22.89 | 2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Innovation Technologies INC | $17.24 | 2024 | Irrisept |
| Hydrofera LLC | $16.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Taarea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.